Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future

Masafumi Imamura, Koichi Hirata, Michiaki Unno, Kinj Kamiya, Mitsukazu Gotoh, Hiroyuki Konno, Akiko Shibata, Kenichi Sugihara, Arata Takahashi, Masahiko Nishiyama, Kenichi Hakamada, Tsuguya Fukui, Toshiharu Furukawa, Tsunekazu Mizushima, Masamichi Mizuma, Hiroaki Miyata, Masaki Mori, Ichiro Takemasa, Toru Mizuguchi, Toshiyoshi Fujiwara

Research output: Contribution to journalArticle

Abstract

Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.

Original languageEnglish
Pages (from-to)189-195
Number of pages7
JournalInternational Journal of Clinical Oncology
Volume24
Issue number2
DOIs
Publication statusPublished - Feb 15 2019
Externally publishedYes

Fingerprint

Practice Guidelines
Japan
Organizations
Budgets
Guidelines
Neoplasms
Federal Government
Validation Studies
Financial Management
Ethics
Registries
Health
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hematology
  • Oncology

Cite this

Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future. / Imamura, Masafumi; Hirata, Koichi; Unno, Michiaki; Kamiya, Kinj; Gotoh, Mitsukazu; Konno, Hiroyuki; Shibata, Akiko; Sugihara, Kenichi; Takahashi, Arata; Nishiyama, Masahiko; Hakamada, Kenichi; Fukui, Tsuguya; Furukawa, Toshiharu; Mizushima, Tsunekazu; Mizuma, Masamichi; Miyata, Hiroaki; Mori, Masaki; Takemasa, Ichiro; Mizuguchi, Toru; Fujiwara, Toshiyoshi.

In: International Journal of Clinical Oncology, Vol. 24, No. 2, 15.02.2019, p. 189-195.

Research output: Contribution to journalArticle

Imamura, M, Hirata, K, Unno, M, Kamiya, K, Gotoh, M, Konno, H, Shibata, A, Sugihara, K, Takahashi, A, Nishiyama, M, Hakamada, K, Fukui, T, Furukawa, T, Mizushima, T, Mizuma, M, Miyata, H, Mori, M, Takemasa, I, Mizuguchi, T & Fujiwara, T 2019, 'Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future', International Journal of Clinical Oncology, vol. 24, no. 2, pp. 189-195. https://doi.org/10.1007/s10147-018-1340-1
Imamura, Masafumi ; Hirata, Koichi ; Unno, Michiaki ; Kamiya, Kinj ; Gotoh, Mitsukazu ; Konno, Hiroyuki ; Shibata, Akiko ; Sugihara, Kenichi ; Takahashi, Arata ; Nishiyama, Masahiko ; Hakamada, Kenichi ; Fukui, Tsuguya ; Furukawa, Toshiharu ; Mizushima, Tsunekazu ; Mizuma, Masamichi ; Miyata, Hiroaki ; Mori, Masaki ; Takemasa, Ichiro ; Mizuguchi, Toru ; Fujiwara, Toshiyoshi. / Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future. In: International Journal of Clinical Oncology. 2019 ; Vol. 24, No. 2. pp. 189-195.
@article{e88a9dfbaddd4b44b92dbf94953d119f,
title = "Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future",
abstract = "Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70{\%}. However, organizations with smaller budgets reported surveying approximately 60{\%} of the time, whereas the ones with larger budgets reported approximately 100{\%} success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.",
author = "Masafumi Imamura and Koichi Hirata and Michiaki Unno and Kinj Kamiya and Mitsukazu Gotoh and Hiroyuki Konno and Akiko Shibata and Kenichi Sugihara and Arata Takahashi and Masahiko Nishiyama and Kenichi Hakamada and Tsuguya Fukui and Toshiharu Furukawa and Tsunekazu Mizushima and Masamichi Mizuma and Hiroaki Miyata and Masaki Mori and Ichiro Takemasa and Toru Mizuguchi and Toshiyoshi Fujiwara",
year = "2019",
month = "2",
day = "15",
doi = "10.1007/s10147-018-1340-1",
language = "English",
volume = "24",
pages = "189--195",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future

AU - Imamura, Masafumi

AU - Hirata, Koichi

AU - Unno, Michiaki

AU - Kamiya, Kinj

AU - Gotoh, Mitsukazu

AU - Konno, Hiroyuki

AU - Shibata, Akiko

AU - Sugihara, Kenichi

AU - Takahashi, Arata

AU - Nishiyama, Masahiko

AU - Hakamada, Kenichi

AU - Fukui, Tsuguya

AU - Furukawa, Toshiharu

AU - Mizushima, Tsunekazu

AU - Mizuma, Masamichi

AU - Miyata, Hiroaki

AU - Mori, Masaki

AU - Takemasa, Ichiro

AU - Mizuguchi, Toru

AU - Fujiwara, Toshiyoshi

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.

AB - Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.

UR - http://www.scopus.com/inward/record.url?scp=85052327931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052327931&partnerID=8YFLogxK

U2 - 10.1007/s10147-018-1340-1

DO - 10.1007/s10147-018-1340-1

M3 - Article

C2 - 30143906

AN - SCOPUS:85052327931

VL - 24

SP - 189

EP - 195

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 2

ER -